(Q52863944)

9 May 2018

title

A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. (English)

1 reference

9 May 2018

1 reference

1 reference

1

Emery P

0 references

author name string

Breedveld FC

2

1 reference

9 May 2018

Lemmel EM

3

1 reference

9 May 2018

Kaltwasser JP

4

1 reference

9 May 2018

Dawes PT

5

1 reference

9 May 2018

Gömör B

6

1 reference

9 May 2018

Van Den Bosch F

7

1 reference

9 May 2018

Nordström D

8

1 reference

9 May 2018

Bjorneboe O

9

1 reference

9 May 2018

Dahl R

10

1 reference

9 May 2018

Horslev-Petersen K

11

1 reference

9 May 2018

Rodriguez De La Serna A

12

1 reference

9 May 2018

Molloy M

13

1 reference

9 May 2018

Tikly M

14

1 reference

9 May 2018

Oed C

15

1 reference

9 May 2018

Rosenburg R

16

1 reference

9 May 2018

Loew-Friedrich I

17

1 reference

9 May 2018

publication date

1 June 2000

1 reference

9 May 2018

published in

Rheumatology

1 reference

9 May 2018

volume

39

1 reference

9 May 2018

page(s)

655-665

1 reference

9 May 2018

issue

6

1 reference

9 May 2018

Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.6.655

The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.6.655

Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.6.655

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.6.655

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.6.655

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.6.655

Second-line drug therapy for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.6.655

The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2F39.6.655

10.1093/RHEUMATOLOGY/39.6.655

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

Dimensions Publication ID

0 references

1 reference

9 May 2018